✦ LIBER ✦

Retrospective analysis of patients with poor prognostic factors and metastatic breast cancer in a phase III study comparing nab-paclitaxel to solvent-based paclitaxel

✍ Scribed by T. Camburn; S. Tjulandin; N. Davidson; J. O'Shaughnessy; P. Bhar; W. Gradishar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

nab-Paclitaxel for first-line treatment

✍ O’Shaughnessy, Joyce; Gradishar, William J.; Bhar, Paul; Iglesias, Jose 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 424 KB

Overall survival analysis of a randomize

✍ N. Davidson; S. Tjulandin; J. O'Shaughnessy; P. Bhar; W. Gradishar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Prognostic and Predictive Value of HER2

✍ Gilcrease, M.Z. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Phase III study of gemcitabine (G) plus

✍ A. Llombart; S. Nag; G. Calderillo-Ruiz; J. Rolski; A. Pluzanska; L. Simms; K. L 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

470 Final results of a phase II study of

✍ S. Glück; C. Lobo; G. Lopes; A. Castrellon; J. Hurley; I. Reis; S. Richman; O. S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Weekly Cisplatin, Epirubicin, and Paclit

✍ Glück, S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB